Study of the formation of Candida albicans and Escherichia coli biofilms

Download full text PDF
DOI: https://doi.org/10.29296/25419218-2019-07-05
Issue: 
7
Year: 
2019

N.P. Sachivkina(1), E.M. Lenchenko(2), A.I. Marakhova(1) 1-Peoples’ Friendship University of Russia, 6, Miklukho-Maklai St., Moscow 117189, Russian Federation; 2-Moscow State University of Food Production, 11, Volokolamskoe Sh., Moscow 125080, Russian Federation

Introduction. Biofilms are a form of microbial communities fixed onto various abiotic and biotic surfaces. This way in which the microorganisms exist creates major problems in pharmaceutical, medical, and veterinary practice. The creation of biofilms by microorganisms makes them inaccessible to the vast majority of antimicrobial agents. The existence of biofilms in chronic infections requires entirely new treatment approaches. Some mechanisms for the formation and maintenance of certain types of biofilms are not yet completely clear. Objective: to comparatively assess and select effective methods for studying the structural and functional features of the formation of biofilms by microscopic fungi and bacteria for the further design of effective pharmacological preparations. Results. The investigators studied the structural and functional features of non-pathogenic strains of microscopic fungi of the genus Candida and bacteria Escherichia coli on the ability to form biofilms by a new modified method. A simple and economical method for producing biofilms was developed, which allows one to study the role of the tube formation process in Candida-Escherichia communities. Conclusion. The proposed model can be used to study the therapeutic effect of various drugs on biofilms and the mechanisms of their initial adhesion.
Keywords: 
microscopic fungi
bacteria
biofilms
adhesive properties
matrix
microscopy
References: 
  1. Abdullahi, Umar Faruk. Intrigues of biofilm: A perspective in veterinary medicine. VeterinaryWorld, 2016; 9 (1): 12–8.
  2. Mal'tsevS.V., MansurovaG.Sh. What is biofilm? Prakticheskaya meditsina, 2011; 53: 7–10 (in Russian)
  3. Lebeaux D., Chauhan L., Rendueles O., Beloin C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens, 2013; 26: 288.
  4. Lenchenko Е.М., Antonova А.N. The study of biofilms and phenotypic signs of bacteria. Veterinariya, 2017; 10: 31–4 (in Russian).
  5. Ramage G., VandeWalle K., Wickes B.L., López-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother, 2001; 45 (9): 2475–9.
  6. SergeevА.Yu., SergeevYu.V. Candidiasis. The nature of the infection, the mechanisms of aggression and defense, laboratory diagnostics, clinic and treatment. Moscow: Triada–X, 2001; 472 (in Russian).
  7. Nett J., Andes D.R. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr. Opin. Microbiol., 2006; 9: 340–5.
  8. Sachivkina N.P., Lenchenko Е.М., Mannapova R.Т., Strizhakov А.А., Romanova Е.V., Lukina D.М. Сandida Biofilm Modeling: Past and Present.Farmatsiya, 2019; 68 (3): 18–22. DOI: 10/29296/25419218-2019-03-03 (in Russian).
  9. Khaitovich А.V., Gaffarova А.S. Pathogenicity factors of Candida albicans and determination of their gene determinants. Tavricheskiy mediko-biologicheskiy vestnik, 2016; 19 (3): 121–6 (in Russian).
  10. Sachivkina N.P., Kulikov Е.V. Formation of germinal tubes in Сandida with a high degree of adhesion.Uspekhi meditsinskoy mikologii, 2016; XV: 33–5 (in Russian).
  11. Chebotar' I.V., Parshikov V.V. Investigation of the effect of antimycotic drugs on biofilms formed by Candida species. Akusherstvo i Ginekologiya, 2013; 5: 98–102 (in Russian).